Drugs / Adult Allogeneic Mesenchymal cells from adipose tissue.
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02687646 | Feb 2017 → Jan 2022 | acute graft versus host disease | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adult Allogeneic Mesenchymal cells from adipose tissue. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02687646 ↗ |
| Known as | MSC | “Study treatment consists of Mesenchymal Stem Cell (MSC) derived from donors adipose tissue and expanded in vitro in a specific medium with platelet lysate without addition of...” NCT02687646 ↗ |
| Modality | Cell therapy | “Study treatment consists of Mesenchymal Stem Cell (MSC) derived from donors adipose tissue” NCT02687646 ↗ |
| Route | Intravenous | “Subjects will receive four sequential IV dose of Mesenchymal stem cells.” NCT02687646 ↗ |